#Sars

John P. Hussman, Ph.D.

hussmanjp

THREAD: Extending the #SARSCoV2 (#COVID_19) updates I started on Feb 2nd (when U.S. had only 5 cases). Each thread has a final post linking to the next.Slow motion train wreck.Click

Walter M Chesnut

Parsifaler

1) RETWEET!!!!!! THE SPIKE PROTEIN OF SARS-CoV-2 IS A "SUPERALLERGEN"!!!!!!! WE ARE "ALLERGIC" TO IT!!!The curious case of MIS-C brings an important concept to mind. Children that present with MIS-C,

Matthew Noah Smith

MattNoahSmith

I’ve been following this story for months and am struck by how confident epidemiologists are here in the US despite the seeming inability of their theories to generalize.https://apnews.com/article/india-dramatic-fall-coronavirus-cases-199

The Binder Lab

TheBinderLab

1/ Viele Diskussionen um #SARSCoV2 / #COVID19 sind recht abstrakt und drehen sich v.a. um Infektionsrouten und die Epidemiologie. Außerdem immer wieder die Frage „Könnt ihr das #Coronavirus überhaupt nachweisen,

Florian Krammer

florian_krammer

1) The low efficacy of the Novavax vaccine candidate against the B.1.351 is concerning. However, the data is also reassuring in many ways. First, the vaccine itself worked very well

SwearyHippieTchr(M.M.)

CrnchyMama

All y’all “reopen the schools now!” peeps, have you signed up to be a substitute teacher? A bus driver? A paraprofessional/aide? How about a custodian? Heck, in some districts you

Theo Sanderson

theosanderson

1/ Had another look at the new Maccabi data. (tl;dr: things look good, but nothing beats a randomised trial) https://theo.io/post/2021-01-31-maccabi-2/ 2/ I extracted the data from the "MHS" Kaplan-Meier plot

Prof. Devi Sridhar

devisridhar

Happy Friday! More good news: Moderna vaccine about to be approved in US & EU. Who would have thought we'd have at least 3 (!) effective & safe vaccines

Andy Conway Morris 😷🧼🇬🇧🇪🇺

andymoz78

Interesting letter from UCLH regarding use of CPAP in Covidhttps://link.springer.com/article/10.1007/s00134-020-06304-y Notable points include the high rate of CPAP use at presentation (86%), as I think the ICU community knows UCLH

Dr. Angela Rasmussen

angie_rasmussen

Phase 3 data from the Sputnik V vaccine is out. ~92 efficacy. Even though we won't get this vaccine here in the US, it's still great news. 1. We need

Avital O'Glasser, MD FACP FHM

aoglasser

I am VERY MUCH #TeamCaseReport, if you weren't already awarein addition to what @IDdocAdi says, want to know why???mini-threadhttps://twitter.com/IDdocAdi/status/1347929237412569089 to start with a line from @HamiltonMusical (no, not th

Billy Bostickson 🏴👁&👁 🆓

BillyBostickson

1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!2 papers:Human–viral molecular mimicryhttps://www.nature.com/articles/s41420-020-00321-yMolecular Mimicryhttps://link.springer.com/articl

Greg Callus

Greg_Callus

The variety of responses in the comments to this tweet is curious. This is my take as an information lawyer, who does primarily solicitor-instructed work, but also does direct access

brenda goodman

ReporterGoodman

Let's talk about that Danish mask study--DANMASK. https://www.acpjournals.org/doi/10.7326/M20-6817 A bit of background... I've been digging into misinformation and disinformation this year for an investigative project. So I've b

Edward Schenck MD

edschenck

The next few weeks/months are going to answer some questions about whether inpatient care for severe #COVID19 has really improved. Unfortunately, I am nervous that the narrative that "the treatment

Michael Mina

michaelmina_lab

Apparently I cannot say this loudly enoughThe recent @bmj_latest articles by @deeksj et al deriding Rapid Ag Innova Tests are simply WRONGThey simply do NOT appropriately interpret Ct values &

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.